NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma

Overview of attention for article published in Frontiers in Genetics, November 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,563 followers.

New Research: NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma: Ewing sarcoma (ES) is a cancer that may originate from stem mesenchymal or neural crest cells and is highly prevalent in children and adolescents. In… https://t.co

26 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.